SCHEMBL29312875

SCHEMBL29312875

O=Cc1ccc(N2CCN(C/C3=C(\c4ccc(Cl)cc4)CCCCCC3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.49
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 2/20 0.45
BCL2 P10415 2/20 0.44
DRD4 P21917 5/20 0.44
DRD3 P35462 3/20 0.43
DRD2 P14416 2/20 0.43
TRIM24 O15164 1/20 0.43
TRIM33 Q9UPN9 1/20 0.43
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
GFER P55789 1/20 0.40
DRD5 P21918 1/20 0.40
CHKA P35790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1540416 1.00 BCL2L1 (0.49) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540223 1.00 BCL2L1 (0.49) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540934 0.99 BCL2L1 (0.50) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540545 0.97 BCL2L1 (0.50) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540145 0.85 TRIM24 (0.44) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1539986 0.84 ALDH1A1 (0.42) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540415 0.84 BCL2L1 (0.49) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540221 0.84 BCL2L1 (0.49) BCL2L1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1540189 0.84 BCL2 (0.48) BCL2L1ALDH1A1KDM4EMAPTBCL2
SCHEMBL1954917 0.83 BCL2L1 (0.70) BCL2L1SMN1; SMN2MAPTBCL2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed